The Motley Fool

NYSE:ZYME (Zymeworks Inc.)

$51.22 $-1.65 (-0.03) Wednesday, January 20, 2021 at 3:07:49 p.m. Eastern Standard Time

About

Last updated Jan 20, 2021, 03:07:49pm EST
Current Price $51.22
Today's Change $-1.65 (-3.1%)
Close Price $52.86
Open Price $53.42
Bid $51.16
Ask $51.27
Day Range $50.53 - $53.42
Year Range $20.33 - $59.03
Volume 391,940
Average Volume 408,539
Market Cap $2,428,700,961.00
EPS (ttm) $-4.43

Related Articles

3 Hot Stocks to Buy in October

Ambrose O'Callaghan | October 2, 2019

Markets are reeling, but investors should still look to add stocks like Zymeworks Inc (TSX:ZYME)(NYSE:ZYME) right now. More »

These Were the Worst-Performing Stocks on the TSX Last Week

Ryan Vanzo | September 16, 2019

Markets keep rising, but there are bargains to be had. Learn more about beaten-down stocks like Imperial Metals Corp (TSX:III), Zymeworks Inc (TSX:ZYME)(NYSE:ZYME), and... More »

3 Top TSX Stocks for the Future

Ambrose O'Callaghan | August 10, 2019

Investors gearing up for the future should target stocks like Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and others. More »

3 Top Canadian Pharma Stocks for Ambitious Investors

Victoria Hetherington | August 5, 2019

Pharma stocks like Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) are coming into their own, offering growth investors a lot of upside potential. More »

3 BioPharm Stocks Yielding 100% Yearly Returns

Debra Ray | July 30, 2019

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME), among other Canadian biopharmaceutical companies, has been hit with shorter supplies and rising demand. More »

3 Top Canadian Healthcare Stocks for Growth Investors

Victoria Hetherington | July 24, 2019

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and two other healthcare stocks may have flown under the radar of recession-proofing investors. More »

This 2017 IPO Still Boasts Massive Growth Potential

Ambrose O'Callaghan | July 14, 2019

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) stock has nearly doubled from its IPO price in 2017, and the biotech’s product candidates should really excite investors. More »

Alert! 2 High-Growth Stocks to Buy Before 2020

Ambrose O'Callaghan | July 8, 2019

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and Stars Group Inc. (TSX:TSGI)(NASDAQ:TSG) are well-positioned to benefit from big growth in their respective markets. More »

Top 2 TSX Healthcare Stocks to Buy in June

Ambrose O'Callaghan | June 9, 2019

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and BELLUS Health Inc. (TSX:BLU) offer huge potential in the burgeoning healthcare sector. More »

This High-Growth Biopharma Stock Just Got Some Great News

Ambrose O'Callaghan | May 5, 2019

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) just saw a top product candidate hit a milestone. This is a growth stock to hold onto into the 2020s. More »